A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
NCT04224506 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
- Myasthenia Gravis
- Myasthenia Gravis, Generalized
Interventions
- OTHER
-
No intervention
There is no intervention for this study.
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Prognosis and Progression of Myasthenia Gravis Patients
NCT04101578 ·Status: UNKNOWN
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
Myasthenia Gravis Foundation of America Global MG Patient Registry
NCT06617741 ·Status: RECRUITING
-
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
NCT06342544 ·Status: RECRUITING ·Phase: PHASE3
-
Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
NCT07243366 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
NCT02473952 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
NCT06064695 ·Status: RECRUITING ·Phase: NA
-
Tissue Repository for Studies of Myasthenia Gravis
NCT02902536 ·Status: COMPLETED
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
NCT00619671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
NCT04535843 ·Status: RECRUITING
-
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
NCT02066519 ·Status: COMPLETED ·Phase: NA
-
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
NCT05214612 ·Status: RECRUITING
-
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
NCT03920293 ·Status: COMPLETED ·Phase: PHASE3
-
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
NCT01828294 ·Status: TERMINATED ·Phase: PHASE1
-
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
NCT05408702 ·Status: COMPLETED
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3
-
A Study in Patients With Myasthenia Gravis in China
NCT06700616 ·Status: ACTIVE_NOT_RECRUITING
-
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
NCT00424489 ·Status: TERMINATED ·Phase: PHASE1
-
A Prospective Cohort Study Of Myasthenia Gravis
NCT04674605 ·Status: UNKNOWN
-
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
NCT00995722 ·Status: TERMINATED ·Phase: PHASE3
-
Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis
NCT05716035 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
NCT06392386 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
NCT06866483 ·Status: RECRUITING